Blue Note Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Blue Note Therapeutics's estimated annual revenue is currently $2.5M per year.(i)
  • Blue Note Therapeutics's estimated revenue per employee is $98,000

Employee Data

  • Blue Note Therapeutics has 26 Employees.(i)
  • Blue Note Therapeutics grew their employee count by -51% last year.

Blue Note Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$212.8M10635%$65MN/A
#2
$35.6M2316%N/AN/A
#3
$45M299-4%$102.6MN/A
#4
$3.2M30-25%$21.3MN/A
#5
$34M2260%$42.9MN/A
#6
$3.6M34-28%$35MN/A
#7
$0.8M10N/AN/AN/A
#8
$12.6M90-9%N/AN/A
#9
$17.4M1240%$96.4MN/A
#10
$5.2M49-25%$75.6MN/A
Add Company

What Is Blue Note Therapeutics?

Blue Note Therapeutics is a prescription digital therapeutics company singularly dedicated to helping patients live better. Blue Note is merging deep scientific and clinical expertise with digital and gaming innovation to transform care for seriously ill patients. Working closely with leading medical researchers and patient advocacy organizations, Blue Note is creating clinically-validated, FDA-approvable prescription-only digital devices to treat the burden of illness. Our team aims to make therapy available to any patient, at any time, on patients' own mobile devices. Patients and clinicians are our partners in developing programs that are highly effective and engaging so that it is easier for patients to stick with them.

keywords:N/A

N/A

Total Funding

26

Number of Employees

$2.5M

Revenue (est)

-51%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Blue Note Therapeutics News

2022-04-19 - Moving the Translational Needle in Breast Cancer ...

Research Funding: Blue Note Therapeutics (Inst). Patents, Royalties, Other Intellectual Property: Related to iron metabolism and the anemia...

2022-03-30 - New Study Finds Cancer-Related Anxiety and Depression are ...

Blue Note Therapeutics is a prescription digital therapeutics company singularly dedicated to serving patients suffering from cancer. We aim to...

2022-03-22 - Blue Note Therapeutics to Present Health Economic Data at ...

SAN FRANCISCO, March 24, 2022 (GLOBE NEWSWIRE) -- Blue Note Therapeutics today announced that new data from a health economic study of...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.7M26-21%N/A
#2
$1.8M26-7%$24.3M
#3
$3.3M26-26%$71.2M
#4
$1.9M26-38%$15.6M
#5
$1.7M26-45%$34.2M